{
  "id": 175150,
  "title": "A COPD drug from China draws $115M in venture funding",
  "url": "https://urgent.news/2026/08/05/a-copd-drug-from-china-draws-115m-in-venture-funding",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-05T12:00:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/expedition-therapeutics-series-b-dpp1-copd-general-atlantic/826874/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Expedition Therapeutics, which has raised nearly $300 million to date, is studying a drug it believes to have notable advantages over other COPD treatments either in development or on the market.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}